171 results
Page 3 of 9
8-K
EX-1.1
ruuihmqgv z003t
26 Jan 21
Invitae Announces Pricing of Public Offering of Common Stock
4:12pm
424B5
a9ou 0of5fqcjdgggcr
25 Jan 21
Prospectus supplement for primary offering
4:02pm
424B5
dwa6c6ect0mu tjmc28
20 Jan 21
Prospectus supplement for primary offering
4:24pm
8-K
2kbfiqg8pym
20 Jan 21
Invitae Announces Proposed Public Offering of Common Stock
4:10pm
8-K
EX-99.2
s0j3ym55 lqa5m8ri6
20 Jan 21
Invitae Announces Proposed Public Offering of Common Stock
4:10pm
8-K
EX-99.1
gwx67azgxbyjc
12 Jan 21
Invitae Reports Preliminary 2020 Financial Results of More Than $278 Million in Revenue and More Than 655,000 in Billable Volume
6:06am
8-K/A
EX-99.1
6sld ukin
23 Nov 20
Consolidated Financial Statements
12:00am
8-K
EX-10.3
66hq3dz1pi a4d
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
424B3
g98ly
28 Aug 20
Prospectus supplement
4:31pm